Geri-TBI: A Prospective Multi-center Evaluation of Geriatric Patients With Traumatic Brain Injury

Sponsor
Methodist Health System (Other)
Overall Status
Recruiting
CT.gov ID
NCT05171010
Collaborator
(none)
60
1
59.1
1

Study Details

Study Description

Brief Summary

This multicenter prospective observational study is designed to prospectively record data on patients who are managed per institutional standard of care. The objectives of this study are to establish an aggregate database of information on baseline clinical and demographic characteristics, medication use, markers of frailty, injury characteristics, management strategies, and outcomes following TBI in geriatric patients, determine best practices for management of geriatric patients with TBI, and establish how markers of frailty correlate with outcome in geriatric patients with TBI.

Condition or Disease Intervention/Treatment Phase
  • Other: no study-based therapeutic interventions

Detailed Description

This is a prospective multi-center observational study of geriatric patients with TBI. Data collected will be purely observational and involve no study-based therapeutic interventions or alterations in patient care. Due to the purpose of this study being the creation of a registry and the absence of demographic information being collected, all patients meeting the inclusion criteria will be enrolled without informed consent. We plan to complete the data collection and analysis by 12/31/2018.

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Geri-TBI: A Prospective Multi-center Evaluation of Geriatric Patients With Traumatic Brain Injury
Actual Study Start Date :
Nov 29, 2017
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Outcome Measures

Primary Outcome Measures

  1. CT scan ["through study completion, an average of 1 year".]

    CT scan-verified traumatic brain injury in patients aged greater than or equal to 40

Secondary Outcome Measures

  1. Comorbidities ["through study completion, an average of 1 year".]

    history of any systemic diseases like diabetes, hypertension, blood pressure

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥40

  • CT-verified TBI

Exclusion Criteria:
  1. Any other body region injury AIS >2

  2. Presentation at enrolling center >24 hours after injury

  3. Pregnant women

  4. Prisoners

Contacts and Locations

Locations

Site City State Country Postal Code
1 Methodist Dallas Medical Center Dallas Texas United States 75203

Sponsors and Collaborators

  • Methodist Health System

Investigators

  • Principal Investigator: Michael Truitt, MD, Methodist Dallas Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Methodist Health System
ClinicalTrials.gov Identifier:
NCT05171010
Other Study ID Numbers:
  • 049.GME.2017.D
First Posted:
Dec 28, 2021
Last Update Posted:
Dec 28, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 28, 2021